Found: 6
Select item for more details and to access through your institution.
Stage IV-S Metastatic Neuroblastoma Presenting as Skin Nodules at Birth.
- Published in:
- International Journal of Dermatology, 1988, v. 27, n. 10, p. 712, doi. 10.1111/j.1365-4362.1988.tb01271.x
- By:
- Publication type:
- Article
Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 6, p. 3479, doi. 10.1245/s10434-023-13120-3
- By:
- Publication type:
- Article
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 6, p. 1306, doi. 10.1007/s10637-022-01311-w
- By:
- Publication type:
- Article
KRAS Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset Colorectal Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345801, doi. 10.1001/jamanetworkopen.2023.45801
- By:
- Publication type:
- Article
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 827, doi. 10.1093/oncolo/oyad096
- By:
- Publication type:
- Article
Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo‐Controlled, Double‐Blind and 32‐Week Open‐Label Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 16, doi. 10.1634/theoncologist.2017-0284
- By:
- Publication type:
- Article